Metastatic Colon Cancer Terminated Phase 3 Trials for Bevacizumab (DB00112)

Also known as: Colon cancer metastatic / Stage IV Colon Cancer / Colon cancer stage IV / Malignant neoplasm of colon stage IV / Colon cancer Duke's D / Malignant neoplasm of colon stage IV, unspecified

IndicationStatusPhase
DBCOND0033231 (Metastatic Colon Cancer)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00070122Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal CancerTreatment